| Patents for C07C 259 - Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups (4,411) |
|---|
| 01/26/2010 | US7652069 Polymorphs of suberoylanilide hydroxamic acid |
| 01/13/2010 | CN100579957C Novel arylamidine derivative or salt thereof |
| 01/06/2010 | EP2139850A1 Inhibitors of histone deacetylase |
| 01/06/2010 | EP2139829A1 N-heterocyclic carbene (nhc) catalyzed synthesis of hydroxamic acids |
| 01/05/2010 | US7642280 Inhibitors of acyl glucosaminyl inositol amidase and methods of use |
| 12/31/2009 | US20090324540 Compounds and compositions for delivering active agents |
| 12/22/2009 | US7635788 Alpha-amino acid derivatives with antiinflammatory activity |
| 12/17/2009 | US20090312365 Certain Chemical Entities, Compositions, and Methods |
| 12/17/2009 | US20090311201 Lipoxin analogs and methods for the treatment of periodontal disease |
| 12/16/2009 | EP2132187A2 Dual-acting antihypertensive agents |
| 12/10/2009 | US20090306127 Certain Chemical Entities, Compositions and Methods |
| 12/09/2009 | EP2130908A2 Retinoid compounds and their use |
| 12/03/2009 | US20090298924 Hydroxamic acid derivatives as inhibitors of hdac enzymatic activity |
| 12/03/2009 | US20090297417 SELECTIVE CATALYTIC NOx REDUCTION PROCESS AND APPARATUS PROVIDING IMPROVED GASSIFICATION OF UREA TO FORM AMMONIA-CONTAINING GAS |
| 12/01/2009 | CA2264556C Substituted n-[(aminoiminomethyl or aminomethyl)phenyl]propyl amides |
| 11/26/2009 | US20090291978 Enzyme Inhibitors |
| 11/25/2009 | EP0931060B1 Substituted n- (aminoiminomethyl or aminomethyl)phenyl propyl amides |
| 11/24/2009 | CA2421504C 2-amino-2-alkyl-5 heptenoic and heptynoic acid derivatives useful as nitric oxide synthase inhibitors |
| 11/24/2009 | CA2389378C 20-hete synthase inhibitor |
| 11/19/2009 | US20090286841 Certain chemical entities, compositions, and methods |
| 11/17/2009 | US7618981 Imidazopyridinyl-benzamide anti-cancer agents |
| 11/11/2009 | EP1255726B1 (r)-2-aryl-propionamides, useful in the inhibition of il-8 induced chemiotaxis of neutrophils |
| 10/22/2009 | US20090261043 Chelating compounds and immobilized tethered chelators |
| 10/14/2009 | CN101555212A Synthesized micromolecule compound capable of conveying bioactivator and application thereof |
| 10/08/2009 | US20090253690 N-[3-(1-piperidinyl)propoxy]-pyridin-1-oxide-3-carboxamidine; cardiovascular disorders; treating dysfunction of endothelial cells |
| 10/06/2009 | US7598289 Ketones and reduced ketones as therapeutic agents for the treatment of bone conditions |
| 10/06/2009 | US7598242 Compounds for the treatment of inflammatory disorders |
| 10/01/2009 | US20090247506 Antibacterial agents |
| 09/30/2009 | CN101544582A Synthetic method of diacetylmonoxime |
| 09/29/2009 | CA2391085C Bis-basic compounds as tryptase inhibitors, processes for preparing them and their use as phamaceutical compositions |
| 09/22/2009 | US7592478 Ligand antagonists of RAR receptors and pharmaceutical/cosmetic applications thereof |
| 09/17/2009 | WO2009113320A1 Mmp inhibitor |
| 09/16/2009 | CN100540530C Alpha-amino acid derivatives with antiinflammatory activity |
| 09/15/2009 | US7589216 Process for preparing N-hydroxyformamido-propyl pyrrolidin compounds and intermediates |
| 09/15/2009 | CA2342985C Hydroxamate-containing cysteine and serine protease inhibitors |
| 09/09/2009 | CN101528677A HDAC inhibitors |
| 09/03/2009 | US20090220454 Use of the histone deacetylase inhibitor N-hydroxy-4-[2-(3-dimethylaminobenzofuran-2-ylcarbonylamino)ethoxy]benzamide (aka CRA-24781, PCI-24781) for treating myelogenous leukemia (MML) or acute myelogenous leukemia (AML), optionally in combination therapy |
| 09/02/2009 | EP1692097B1 Tricyclic hydroxamate and benzamide derivatives, compositions and methods |
| 09/02/2009 | CN101519365A Improved production method for salicylhydroxamic acid |
| 09/01/2009 | US7582668 to treat cellular proliferative diseases, hyperplasias, solid tumor, cardiac hypertrophy, immune disorders and inflammation; modulators of one or more mitotic kinesins; N-(2-(2-dimethylamino-acetylamino)-1-{4-[8-(1-hydroxy-ethyl)-imidazo[1,2-a]pyridin-2-yl]-benzyl}-ethyl)-3-chloro-4-isopropoxy-benzamide |
| 09/01/2009 | CA2272540C Anti-oxidizing composition for scavenging free radicals, pharmaceutical composition comprising the same, and process for preparing the same |
| 08/27/2009 | WO2008154905A3 Modifications of the histone deacetylase inhibitor suberoylanilide hydroxamic acid |
| 08/26/2009 | CN101514171A One-step method for synthesizing N-methyl-N-methoxyamide |
| 08/19/2009 | CN101511993A Retinoid compounds and their use |
| 08/13/2009 | WO2009098515A1 Novel process for the preparation of vorinostat |
| 08/13/2009 | US20090202449 Use of osteopontin in dental formulations |
| 08/13/2009 | CA2712858A1 Novel process for the preparation of vorinostat |
| 08/12/2009 | CN101506151A Improvement of the bioavailability of active substances having an amidine function in medicaments |
| 08/12/2009 | CN101503373A 2-amino-1-(4-nitro phenyl)-1-ethanol metalloid protease inhibitor, and preparation and use thereof |
| 08/11/2009 | US7572825 4-(t-Butyldiphenylsiloxy)pentyl-p-toluene sulfonate; 2,2-[4-Biphenyl-5-(t-butyldiphenylsiloxy)pentyl)]-1,3-propanedithiane; osteoporosis, rheumatoid arthritis, cancer associated bone disease, Paget's disease, aseptic loosening of prosthetic implants; inflammation |
| 08/05/2009 | EP1461313B1 Human adam-10 inhibitors |
| 08/05/2009 | EP1383731B1 Biaryl compounds as serine protease inhibitors |
| 08/05/2009 | CN100522944C Carboxylic acid derivative and thereof |
| 08/05/2009 | CN100522921C Novel antihistaminic piperidine derivatives and intermediates for the preparation thereof |
| 08/04/2009 | US7569724 Antiproliferative agnets; anticancer agents; skin disorders |
| 07/29/2009 | EP2083005A1 Carbamic acid compounds comprising an amide linkage as HDAC inhibitors |
| 07/29/2009 | EP2082737A2 Methods of inducing terminal differentiation |
| 07/22/2009 | EP2079304A1 Amine base salts of saha and polymorphs thereof |
| 07/22/2009 | EP1115390B1 Hydroxamate-containing cysteine and serine protease inhibitors |
| 07/16/2009 | US20090181971 Inhibitors of Histone Deacetylase |
| 07/15/2009 | CN100513386C Amide for inhibition of IL-8-induced chemiotaxis of neutrophil leucocytes |
| 07/09/2009 | WO2008154642A3 Antibacterial agents |
| 07/09/2009 | WO2008136976A3 Compounds for treating proliferative disorders |
| 06/30/2009 | US7553872 Compounds and compositions for delivering active agents |
| 06/25/2009 | US20090163543 Histone Deacetylase Inhibitors and Methods of Use Thereof |
| 06/25/2009 | US20090163496 Antibacterial agents |
| 06/23/2009 | US7550457 Therapy of vascular system diseases |
| 06/17/2009 | EP2069291A1 Hdac inhibitors |
| 06/17/2009 | EP1611088B1 Hydroxamates as therapeutic agents |
| 06/17/2009 | EP1383736B1 Peptide deformylase inhibitors |
| 06/16/2009 | US7547802 Compounds for the treatment of metabolic disorders |
| 06/09/2009 | US7544835 Carboxylic acid derivative and salt thereof |
| 06/04/2009 | WO2009067856A1 Histone deacetylase inhibitor, composition and use thereof |
| 06/04/2009 | WO2007113644A3 New hdac inhibitors |
| 06/03/2009 | EP2065366A2 HIF hydroxylase inhibitors |
| 06/03/2009 | CN101444496A Compounds for the treatment of metabolic disorders |
| 05/28/2009 | US20090137679 ZN2+Chelating Motif-Tethered Short-Chain Fatty Acids as a Novel Class of Histone Deacetylase Inhibitors |
| 05/19/2009 | US7534918 Histone deacetylase inhibitors |
| 05/19/2009 | CA2209167C Hydroxylamine derivatives useful for enhancing the molecular chaperon production and the preparation thereof |
| 05/13/2009 | EP1687301B1 Thiaepothilone for treating cancerous diseases |
| 05/12/2009 | US7531573 Use of triaryl methane compounds for inhibiting unwanted cellular proliferation associated with inflammatory disease |
| 05/07/2009 | WO2009055917A1 Inhibitors of histone deacetylase |
| 05/07/2009 | WO2009055863A1 Desferrioxamine conjugates, derivatives and analogues |
| 05/07/2009 | CA2703718A1 Inhibitors of histone deacetylase |
| 05/06/2009 | EP2054504A2 Retinoid compounds and their use |
| 05/05/2009 | US7528260 Method for preparing N-phenylpyrazole-1-carboxamides |
| 04/30/2009 | WO2009053808A2 Histone deacetylase inhibitors |
| 04/30/2009 | CA2703231A1 Histone deacetylase inhibitors |
| 04/29/2009 | EP1485347B1 Hif hydroxylase inhibitors for use in the treatment of anaemia |
| 04/29/2009 | CN100482638C N-acylaminobenzene dervatives as selective monoamine oxidase b inhibitors |
| 04/23/2009 | US20090105168 Use Of HDAC And/Or DNMT Inhibitors For Treatment Of Ischemic Injury |
| 04/22/2009 | EP2050036A2 Potentiation of antifungal compounds |
| 04/22/2009 | EP1585757A4 Peptide deformylase inhibitors |
| 04/21/2009 | US7521510 Monoamidine-based, bisamidine-based, and monoamidoxime-based curatives, co-curatives and cure accelerators for perfluoroelastomeric compositions; co-curatives and cure accelerators having high molecular weight |
| 04/16/2009 | WO2009047615A2 Novel histone deacetylase inhibitors |
| 04/16/2009 | WO2008147480A4 Hydroxamic acid derivatives of 3-phenyl propionic acids useful as thrapeutic agents for treating anthrax poisoning |
| 04/16/2009 | CA2702536A1 Novel histone deacetylase inhibitors |
| 04/15/2009 | EP2046732A1 Improvement of the bioavailability of active substances having an amidine function in medicaments |
| 04/14/2009 | US7517988 N-hydroxy-4-[2-(benzofuran-2-ylcarbonylamino)ethylsulfonyl]-benzamide; hepatitis C; inhibitors of histone deacetylase |
| 04/09/2009 | WO2006052916A3 Histone deacetylase inhibitors |